Great point. With the multiple sites open for enrollment, a number of them in populous areas, the enrollment hopefully won’t take too long. And because this is cancer, and a deadly one, even results from a 40 patient trial should be very exciting. The interesting part of this trial is how the metastasis can be measured via the blood. Hard to argue a “placebo” effect when there’s a test to prove the result.